Dice CEO: Energy, T...
Health Care: Drugs
Accelr8 Technology Corporation (AXK: AMEX)
$3.48 0.81 | 30.34%
06/01/12 - 04:03 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 3.48 |
| 52 Week High | 7.80 |
| 52 Week Low | 0.76 |
| Avg. Daily Vol. (Mil) | 0.06 |
| Beta (3 year) | 0.88 |
| Share Related Items | |
| Mkt Cap (Mil) | 38.64 |
| Shares Out (Mil) | 11.10 |
| Float (Mil) | 9.59 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.80 |
| Current Ratio | 5.10 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 70.05 |
| Price/Book | 8.88 |
| Price/Cash Flow | -42.20 |
| Per Share Data | |
| Earnings | -0.11 |
| Sales | 0.05 |
| Book Value | 0.39 |
| Cash Flow | -0.08 |
| Business Summary | |
|---|---|
| Accelr8 Technology Corporation develops BACcel system, planned for rapid diagnosis in life-threatening bacterial infections. It has also developed and out-licensed OptiChem surface coatings for use in microarraying components. | |
| General Information | |
| 7000 N Broadway
Building 3-307 Denver, CO 80221 |
|
| www.accelr8.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 8 | |
| CEO: Mr. Thomas V. Geimer | |
| Short Interest | |
| Current Month (Mil) | 0.15 |
| Previous Month (Mil) | 0.15 |
| Short Interest Ratio (Days) | 1.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -19.50 |
| Return on Investments | -27.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with AXK
- Portfolio NameUser Type
- ContributorBest-Performing Stocks Unde...
- Contributor10 Best-Performing Stocks U...
- Contributor10 Best-Performing Stocks U...
- UserMary
- UserBerridge Investments
- Userlaredo Portfolio 1
- Usergenomiks BIOMED
- UserPANTERA GROUP 169(SUPRATRADE)
- UserBenitrans GStock II
- UserCharles
Latest AXK Headlines from TheStreet
- Accelr8 Technology Corporation Stock Downgraded (AXK) 11.02.11 | 07:11 am
- Accelr8 Technology Stock Soars (AXK) 10.12.11 | 10:10 am
- Accelr8 Technology Stock Soars (AXK) 10.05.11 | 02:10 pm
- Best-Performing Stocks Under $5 in 2011 09.28.11 | 01:09 pm
- Best-Performing Stocks Under $5 in 2011 08.31.11 | 06:08 am
- Accelr8 Technology Stock Gaps Up On Today's Open (AXK) 06.30.11 | 10:06 am
- Accelr8 Technology Stock Soars (AXK) 06.22.11 | 02:06 pm
- Accelr8 Technology Stock Soars (AXK) 06.09.11 | 10:06 am
- 10 Best-Performing Stocks Under $5 This Year 04.27.11 | 06:04 am
- 10 Best-Performing Stocks Under $5 This Year 03.30.11 | 07:03 am
Press Releases for AXK
- Accelr8 Attracts Up To $35 Million Private Equity Investment - Business Wire 04.23.12 | 03:04 pm
- Accelr8 Announces Interim Plan And Advanced Studies - Business Wire 10.13.11 | 07:10 am
- Accelr8 Announces Renewal And Expansion Of SCHOTT Microarray License, And Notice Of Allowance For New Patent - Business Wire 09.22.11 | 08:09 am
- Accelr8 Announces Results In Award-Winning Presentation For Rapid Diagnostics With ICU Specimens - Business Wire 09.19.11 | 10:09 am
- Accelr8 Announces Continuation And Expansion Of BACcel™ Development Collaboration - Business Wire 07.25.11 | 08:07 am
- Accelr8 To Receive Award For ICAAC Presentation - Business Wire 07.18.11 | 07:07 am
- Accelr8 Announces Continuation Of BACcel™ Collaboration - Business Wire 06.30.11 | 05:06 pm
- Accelr8 States That Its Policy Is Not To Comment On Unusual Market Activity Or Rumors - Business Wire 06.09.11 | 11:06 am
- Accelr8 4-Hour Test Identifies New Drug-Resistant “Staph” (hVISA) Undetectable By Hospital Labs - Business Wire 05.23.11 | 07:05 am
- Accelr8 States That Its Policy Is Not To Comment On Unusual Market Activity Or Rumors - Business Wire 05.19.11 | 05:05 pm
Partner Headlines for AXK
- Accelr8 Technology Corp: Invest At Your Own Risk - Seeking Alpha 06.24.11 | 09:06 am
